We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Innovative Coating Relieves Catheter Insertion Pain

By HospiMedica International staff writers
Posted on 17 Mar 2015
A new slippery coating aims to make catheter insertions easier, less painful, and with a reduced risk of inflammation or infection.

Developed by researchers at Queen's University Belfast (QUB; United Kingdom), Uroglide technology is intended for intermittent self-catheterization (ISC) patients who insert and remove disposable catheters themselves between four and eight times per day. More...
The new coating, although cheaper than the current industry standard polyvinyl pyrrolidone (PVP) lubricant, stays wet for longer, is more slippery, and adheres more strongly to the catheter. By easing insertion and removal, it improves the patient’s experience and make a life-changing difference to their dignity and health.

Potential benefits of the Uroglide coating include a low coefficient of friction, easy insertion and removal, reduced urethral trauma, enhanced dry-out times (which provide additional time for limited-dexterity users to achieve insertion), improved user satisfaction, and compatibility with standard coating methods. In a range of laboratory tests and human haptic assessments, Uroglide demonstrated a coefficient of friction value up to 40% lower than PVP, and two-fold longer retention of water. Uroglide will be distributed by QUB spinoff Uroglide (Belfast, Ireland), and will become commercially available in 2016.

“For patients with poor control over their bladders, intermittent self-catheterization, which involves the regular insertion of catheters into the bladder via the urethra, has become the norm,” said Prof. Colin McCoy, PhD, of the QUB School of Pharmacy. “Regular insertion of poorly lubricated catheters, however, is painful and can lead to difficult-to-treat urethral complications, such as damage, bleeding, and inflammation. The coatings that are currently used dry out quickly and they've changed very little in over a decade.”

Related Links:

Queen's University Belfast
Uroglide



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.